Patent · US Active

Combination comprising immunostimulatory oligonucleotides

US10487333B2 · kind B2 · utility

7Cited by

2References

3Claims

0Family size

Assignee

Mologen AG · DE

Inventors

Matthias Schroff · Berlin, DE
Manuel Schmidt · Berlin, DE
Kerstin Kapp · Berlin, DE
Alfredo Zurlo · Berlin, DE

Key dates

Filing date	Sep 9, 2016
Grant date	Nov 26, 2019
Priority date	—
Expiry date	Sep 9, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/31
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a combination and its use for the treatment of diseases. The instant disclosure provides a combination of a so-called T-cell regulator selected from the group comprising PD1, PD-L1, OX40, TIM-3, LAG3, CD137(4-1BB) and a non-coding immunomodulating DNA.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.